PCM
NBP

Prelude Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Prelude Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,600
Closed -$176K – 1739
2022
Q2 		$176K Buy
+15,600
New +$187K 0.01% 1323

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Prelude Capital Management's NBP Position: Q2 2024 in Review

Prelude Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2024, closing a stake of 81,262 shares — an estimated $151K sold.

Prelude Capital Management first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $228K in Q2 2022. 38 funds tracked by Wall St. Rank hold NBP as of Q2 2024.

  • Prelude Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 81,262 NovaBridge Biosciences American Depositary Shares shares in Q2 2024, an estimated $151K.
  • Prelude Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
  • Prelude Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $228K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.